Oncology

Non-Small Cell Lung Cancer

Patient Care Perspectives Podcast: The Multimodal Treatment of Non–Small Cell Lung Cancer

patient care perspectives by Narjust Florez, MD, FASCO

Overview

In this non–small cell lung cancer (NSCLC) podcast, Narjust Florez, MD, FASCO, discusses how multidisciplinary teams can coordinate systemic therapy, surgery, radiation therapy, supportive care, and survivorship planning for patients with NSCLC who are younger than 50 years of age. Dr Florez also reviews the evolving use of local therapy for oligopersistent and oligoprogressive disease as part of the broader multimodal treatment paradigm in NSCLC.

References

Deng J, Yang M, Zhou Q. Local consolidative therapy in oligometastatic non-small-cell lung cancer after effective systemic treatment: who will benefit? Cancer Biol Med. 2025;22(1):21-27. doi:10.20892/j.issn.2095-3941.2024.0456

Florez N, Kiel L, Kaufman R, et al. Young lung cancer: from diagnosis to survivorship. Front Oncol. 2025;15:1570143. doi:10.3389/fonc.2025.1570143

Florez N, Kiel L, Meza K, et al. Sexual Health Assessment in Women with Lung Cancer study: sexual health assessment in women with lung cancer. Cancer. 2024;130(3):375-384. doi:10.1002/cncr.35057

LoPiccolo J, Gusev A, Christiani DC, Jänne PA. Lung cancer in patients who have never smoked – an emerging disease. Nat Rev Clin Oncol. 2024;21(2):121-146. doi:10.1038/s41571-023-00844-0

Profile

Narjust Florez, MD, FASCO

Associate Medical Director, Cancer Care Access Program
Codirector, Young Lung Cancer Program
Thoracic Medical Oncologist
Dana-Farber Cancer Institute
Assistant Professor of Medicine
Harvard Medical School
Boston, MA